solifenacin succinate has been researched along with Bladder Diseases in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (61.54) | 29.6817 |
| 2010's | 4 (30.77) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Deo, A; Dhamala, JN; Pradhan, T; Yadav, SK | 1 |
| Alexandre, L; Audet, A; Behr-Roussel, D; Bernabé, J; Caisey, S; Charon, C; Giuliano, F; Kergoat, M; Oger-Roussel, S | 1 |
| Cao, Z; Guo, F; Pan, A; Peng, S; Sun, Y; Wang, H; Wang, L; Wei, R; Xu, C; Zhang, C; Zhang, Z | 1 |
| Chłosta, P; Heinze, S; Jakubowicz, J; Jaszczyński, J; Kojs, Z; Rys, J; Stelmach, A; Wohadło, Ł; Łuczyńska, E | 1 |
| Ishida, H; Omoto, K; Shimizu, T; Tanabe, K; Tsunoyama, K | 1 |
| Araño, P; Bosch, JL; Chapple, CR; De Ridder, D; Kramer, AE; Ridder, AM | 1 |
| Al-Shukri, S; Chapple, CR; Everaert, K; Huang, M; Meffan, P; Rechberger, T; Ridder, A | 1 |
| Cardozo, L; Drogendijk, TE; Huang, M; Kuzmin, I; Lisec, M; Millard, R; Ridder, AM; van Vierssen Trip, O | 1 |
| Cardozo, L; Chapple, CR; Haab, F; Kelleher, CJ; Ridder, AM | 1 |
| Brunton, S; Kuritzky, L | 1 |
| Cardozo, L; Robinson, D | 1 |
3 review(s) available for solifenacin succinate and Bladder Diseases
| Article | Year |
|---|---|
Improved quality of life in patients with overactive bladder symptoms treated with solifenacin.
Topics: Adult; Double-Blind Method; Female; Humans; Interpersonal Relations; Male; Multicenter Studies as Topic; Muscarinic Antagonists; Quality of Life; Quinuclidines; Randomized Controlled Trials as Topic; Solifenacin Succinate; Tetrahydroisoquinolines; Treatment Outcome; Urinary Bladder Diseases; Urinary Incontinence | 2005 |
Recent developments in the management of overactive bladder: focus on the efficacy and tolerability of once daily solifenacin succinate 5 mg.
Topics: Administration, Oral; Clinical Trials, Phase III as Topic; Humans; Muscarinic Antagonists; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Urinary Bladder Diseases; Urination Disorders | 2005 |
Solifenacin in the management of the overactive bladder syndrome.
Topics: Clinical Trials as Topic; Humans; Quinuclidines; Receptor, Muscarinic M3; Solifenacin Succinate; Syndrome; Tetrahydroisoquinolines; Urinary Bladder Diseases; Urinary Incontinence; Urination Disorders | 2005 |
5 trial(s) available for solifenacin succinate and Bladder Diseases
| Article | Year |
|---|---|
Solifenacin is able to improve the irritative symptoms after transurethral resection of bladder tumors.
Topics: Cystectomy; Cystitis; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Prospective Studies; Quinuclidines; Remission Induction; Single-Blind Method; Solifenacin Succinate; Tetrahydroisoquinolines; Urinary Bladder Diseases; Urinary Bladder Neoplasms; Urinary Bladder, Overactive; Urination Disorders | 2014 |
Improvement of urinary dysfunction after kidney transplantation by administration of the antimuscarinic agent--prospective randomized controlled study.
Topics: Adult; Female; Health Surveys; Humans; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Muscarinic Antagonists; Postoperative Complications; Prospective Studies; Quality of Life; Quinuclidines; Renal Dialysis; Solifenacin Succinate; Surveys and Questionnaires; Tetrahydroisoquinolines; Treatment Outcome; Urinary Bladder; Urinary Bladder Diseases | 2012 |
Solifenacin appears effective and well tolerated in patients with symptomatic idiopathic detrusor overactivity in a placebo- and tolterodine-controlled phase 2 dose-finding study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Benzhydryl Compounds; Cresols; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Quinuclidines; Single-Blind Method; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder Diseases; Urinary Retention; Urination | 2004 |
Randomized, double-blind placebo- and tolterodine-controlled trial of the once-daily antimuscarinic agent solifenacin in patients with symptomatic overactive bladder.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Benzhydryl Compounds; Cresols; Double-Blind Method; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder Diseases; Urination Disorders | 2004 |
Randomized, double-blind placebo controlled trial of the once daily antimuscarinic agent solifenacin succinate in patients with overactive bladder.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Double-Blind Method; Drug Administration Schedule; Humans; Middle Aged; Muscarinic Antagonists; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Urinary Bladder Diseases; Urinary Incontinence | 2004 |
5 other study(ies) available for solifenacin succinate and Bladder Diseases
| Article | Year |
|---|---|
Patient Perception of Bladder Condition after Treatment with Solifenacin and Tolterodine in Overactive Bladder Patients.
Topics: Benzhydryl Compounds; Cresols; Cross-Sectional Studies; Humans; Nepal; Perception; Phenylpropanolamine; Solifenacin Succinate; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder; Urinary Bladder Diseases; Urinary Bladder, Overactive | 2023 |
Bladder and erectile dysfunctions in the Type 2 diabetic Goto-Kakizaki rat.
Topics: Animals; Diabetes Complications; Diabetes Mellitus, Type 2; Erectile Dysfunction; Male; Penile Erection; Piperazines; Purines; Quinuclidines; Rats; Rats, Wistar; Sildenafil Citrate; Solifenacin Succinate; Sulfones; Tetrahydroisoquinolines; Urinary Bladder; Urinary Bladder Diseases; Urination; Urological Agents; Vasodilator Agents | 2014 |
Post-Irradiation Bladder Syndrome After Radiotherapy of Malignant Neoplasm of Small Pelvis Organs: An Observational, Non-Interventional Clinical Study Assessing VESIcare®/Solifenacin Treatment Results.
Topics: Adult; Female; Humans; Male; Middle Aged; Pelvic Neoplasms; Pelvis; Quality of Life; Radiation Injuries; Solifenacin Succinate; Syndrome; Treatment Outcome; Urinary Bladder; Urinary Bladder Diseases | 2016 |
New molecular entity: Vesicare, Yamanouchi/GlaxoSmithKline solifenacin.
Topics: Administration, Oral; Drug Approval; Drug Interactions; Humans; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; United States; United States Food and Drug Administration; Urinary Bladder Diseases | 2005 |
Solifenacin and darifenacin for overactive bladder.
Topics: Benzofurans; Drug Interactions; Humans; Muscarinic Antagonists; Pyrrolidines; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Urinary Bladder Diseases; Urinary Incontinence | 2005 |